Progress in Mind
Your Psychiatry and Neurology online resource center
Choose a channel
Check out the different Progress in Mind content channels.
Depression, Bipolar
Congress highlights
Are non-communicable diseases communicable? The role of the microbiome in mental illness
Gut microbes influence brain function and behaviour through a variety of neural, endocrine and...
Schizophrenia
Podcast
Addressing the unmet need of cognitive dysfunction in schizophrenia
Metacognition needs to be an important component of cognitive remediation therapy (CRT) to...
Migraine
Congress highlights
When is a migraine not a migraine?
If a patient with migraine develops a thunderclap headache or experiences a change in aura, is the...
Migraine
Congress highlights
Can chronic migraine be prevented by targeting risk factors?
Many risk factors have been identified for predicting the transition from episodic to chronic...
Migraine
Satellite symposium
Migraine care in the covid-19 era: prevention is better than cure
Is there a risk of further de-prioritization of migraine care in the Covid-19 era? This was one of...
Depression
Article
Masculinity meets aging: a toxic mix in older men
The debilitating mental health effects of physical decline, lack of economic productivity, and poor...
Depression
Article
Can gender-specific screening tools aid recognition of male depression?
Only 8.5% of men with symptoms of major depression are currently receiving professional support...
Depression
Article
Depression in men: less frequent, or just less recognized?
International Men’s Day, among other aims, seeks to increase awareness of health challenges...
Schizophrenia
Podcast
Biomarkers - the Future of Diagnosis in Psychiatry?
Diagnosis of psychiatric disorders currently depends on clinical criteria. In the future the hope...
Migraine
Satellite symposium
CGRP antibodies can help alleviate difficult-to-treat migraine
Clinicians and researchers are continually expanding our understanding of disease mechanisms and...
Migraine
Congress highlights
If at first you don’t succeed, try another CGRP antibody for migraine prevention?
If the first monoclonal antibody targeting calcitonin gene-related peptide fails to adequately...
Depression, Bipolar
Congress highlights
Lived experience advice: How can physicians, friends and family best support patients with bipolar disorder?
What type of social support do patients with bipolar disorder find most empowering? Valuable...
Featured articles
THINC®
Depression
Seminar
THINC® Online Course
Download
Download THINC-it® tool
Depression
Download
THINC-it® physician guide
The THINC-it® user guide is now available and can be downloaded here.
Depression
Interview
THINC-it® tool has now been validated! Its importance for measurement-based care in depression
Depression
Article
THINC-it® cognition screening tool now clinically validated
Depression
Article
Infographic for the health care provider describing THINC-it® as a simple, quick and effective way to screen for cognitive dysfunction in depression
Depression
Article
THINC-it® participant leaflet now available
Recommended videos
Video
Expert Views
Video
Expert Views
Two sides of the same coin
7m:19s
Interview
Professor James MacCabe defines Treatment Resistance Schizophrenia
3m:27s
Video
Expert Views
Professor Mark Opler - Teaming up with patients
9m:09s
Video
Expert Views
Improvement in schizophrenia: Long and short term perspectives
5m:39s
Interview
John FP Bridges – Priorities of people living with SCZ
3m:39s
Video
Better understanding of depression, its symptoms and treatment, is needed
3m:39s
Interview
Control of side effects may be the key to solving the dopamine paradox of schizophrenia
3m:44s
Video
Expert Views
Expert insight: on residual and cognitive symptoms in MDD
Interview
John FP Bridges - Aiming for recovery: the world before Schizophrenia
4m:21s
Most popular on Progress in Mind
Depression, Schizophrenia
Article
ICD-11 – fielding for diagnostic success
In 2018, the World Health Organization (WHO) will release two important documents, both of which should aid for the better diagnosis of mental illness; the newer
Depression
Congress highlights
When to change first-line treatment: Debating an everyday dilemma
Schizophrenia
Congress highlights
Mapping of early intervention programs for psychosis in France
Schizophrenia
Congress highlights
Dopamine D2 partial agonists – efficacy, tolerability and improved functioning?
Parkinson's Disease
Congress highlights
Getting rid of alpha-synuclein – active and passive immunotherapy, or maybe targeting LRRK2?
Alzheimer's Disease
Article
Advances in the early diagnosis of Alzheimer’s Disease
Article